<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, in contrast to squamous oesophageal <z:mp ids='MP_0002038'>carcinomas</z:mp>, K-ras point mutations are thought to be a frequent event </plain></SENT>
<SENT sid="1" pm="."><plain>The frequency of K-ras point mutations in premalignant forms of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (<z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>) leading to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> with increased risk is currently not known </plain></SENT>
<SENT sid="2" pm="."><plain>To establish the frequency of K-ras mutations in premalignant forms of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, we investigated oesophageal biopsy specimens with Barrett's metaplastic and dysplastic epithelium for point mutations in the K-ras gene/codons 12, 13 </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: A total of 412 biopsies from patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were histologically classified into biopsies with <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (n = 252), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 105) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 11), as well as biopsies distant from disease (<z:mpath ids='MPATH_458'>normal</z:mpath>, n = 37 and hyperplastic squamous epithelium, n = 7) </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: DNA from biopsy specimens was amplified by polymerase chain reaction (PCR) with a modified primer for generating a restriction site in the case of <z:mp ids='MP_0002169'>wild type</z:mp> in codon 12 </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> or point mutations in the K-ras gene/codons 12, 13 were detected by restriction fragment length analysis of the PCR products </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Point mutations in K-ras/codon 12 were found in 9 biopsies (n = 1 in <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, n = 4 in <z:mpath ids='MPATH_589'>dysplasias</z:mpath>, n = 4 in <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the other biopsies showed the <z:mp ids='MP_0002169'>wild type</z:mp> of K-ras/codon 12 </plain></SENT>
<SENT sid="8" pm="."><plain>No K-ras/codon 13 mutation (GGCgly--&gt;GACasp) was observed </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Mutations in K-ras/codon 12 were rarely found in premalignant forms of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Whereas the screening for K-ras point mutations in metaplastic sites of Barrett's epithelium seems not to be of practical value, the screening for mutations in dysplastic lesions might be helpful to estimate the individual risk for progression of Barrett's epithelium to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>A further evaluation in larger numbers of patients is needed </plain></SENT>
</text></document>